Abstract
There are no cohort studies describing outcomes of patients colonized with vancomycin-resistant enterococci (VRE) undergoing allogeneic hematopoietic stem cell transplantation (AHSCT). We therefore conducted a retrospective cohort study of 217 consecutive adults undergoing AHSCT at the Mayo Clinic (Rochester, MN, USA) from 1998 to 2004. We analyzed the association between VRE colonization prior to transplant and 100-day post transplant mortality and morbidity. We identified 22 pretransplant VRE colonized patients and 195 non-colonized patients. Both groups had similar baseline characteristics with the following six exceptions. Colonized patients were more likely to have had pretransplant Clostridium difficile-associated diarrhea, pretransplant acute renal failure, AML, Cy/TBI conditioning, decreased platelet count at time of transplantation and myeloablative conditioning regimens. Overall, patients colonized with VRE were twice as likely to die by day 100 post transplant compared to non-colonized patients (hazard ratio: 2.1, P=0.028). This association persisted even after adjusting for differences in baseline characteristics. Increased mortality in the colonized group correlated with the presence of VRE bacteremia. Overall, pretransplant VRE colonization appears to be an independent risk factor for increased mortality post-AHSCT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Biedenbach DJ, Moet GJ, Jones RN . Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 2004; 50: 59–69.
Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP . Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234–1239.
Poduval RD, Kamath RP, Corpuz M, Norkus EP, Pitchumoni CS . Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance. Am J Gastroenterol 2000; 95: 3513–3515.
Joels CS, Matthews BD, Sigmon LB, Hasan R, Lohr CE, Kercher KW et al. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections. Am Surg 2003; 69: 514–519.
El-Khoury J, Fishman JA . Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial. Transpl Infect Dis 2003; 5: 121–125.
Yoo JH, Lee DG, Choi SM, Choi JH, Shin WS, Kim M et al. Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course. J Korean Med Sci 2005; 20: 169–176.
DiazGranados CA, Jernigan JA . Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191: 588–595.
Brennen C, Wagener MM, Muder RR . Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc 1998; 46: 157–160.
Patel R . Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51 (Suppl 3): iii13–iii21.
Zaas AK, Song X, Tucker P, Perl TM . Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002; 35: 1139–1146.
Johnston PB, Elliott MA, Ansell SM, Dispenzieri A, Gastineau DA, Gertz MA et al. Colonization with vancomycin-resistant enterococcus correlates with poor outcome in patients undergoing allogeneic blood and marrow transplants. Blood 2000; 96: 786a.
Kumar S, DeLeve LD, Kamath PS, Tefferi A . Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003; 78: 589–598.
Cutler C, Antin JH . An overview of hematopoietic stem cell transplantation. Clin Chest Med 2005; 26: 517–527.
Sloan LM, Uhl JR, Vetter EA, Schleck CD, Harmsen WS, Manahan J et al. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol 2004; 42: 2636–2643.
Mielcarek M, Storb R . Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation. Leuk Lymphoma 2005; 46: 1251–1260.
Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood 2004; 104: 961–968.
Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007; 13: 615–621.
Gratwohl A, Brand R, Apperley J, Biezen Av A, Bandini G, Devergie A et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 2002; 100: 3877–3886.
Gratwohl A, Hermans J, Apperley J, Arcese W, Bacigalupo A, Bandini G et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood 1995; 86: 813–818.
Dubberke ER, Hollands JM, Georgantopoulos P, Augustin K, DiPersio JF, Mundy LM et al. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transplant 2006; 38: 813–819.
Avery R, Kalaycio M, Pohlman B, Sobecks R, Kuczkowski E, Andresen S et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005; 35: 497–499.
Such J, Runyon BA . Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669–674; quiz 675–676.
Guarner C, Runyon BA, Young S, Heck M, Sheikh MY . Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372–1378.
Runyon BA, Squier S, Borzio M . Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21: 792–796.
Tu W, Chen J, Xiao G . [Effects of quinacrine on gut-origin bacteria/endotoxin translocation in rats with gut ischemia/reperfusion injury]. Zhonghua Shao Shang Za Zhi 2001; 17: 301–303.
Von Bultzingslowen I, Adlerberth I, Wold AE, Dahlen G, Jontell M . Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol 2003; 18: 278–284.
Yao YM, Yu Y, Sheng ZY, Tian HM, Wang YP, Lu LR . Role of gut-derived endotoxaemia and bacterial translocation in rats after thermal injury: effects of selective decontamination of the digestive tract. Burns 1995; 21: 580–585.
Tsuji E, Hiki N, Nomura S, Fukushima R, Kojima J, Ogawa T et al. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 2003; 107: 303–308.
Bonten MJ, Willems R, Weinstein RA . Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314–325.
Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G, Fuchs HJ et al. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001; 33: 1476–1482.
Herrero IA, Issa NC, Patel R . Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346: 867–869.
Long JK, Choueiri TK, Hall GS, Avery RK, Sekeres MA . Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia. Mayo Clin Proc 2005; 80: 1215–1216.
Plosker GL, Figgitt DP . Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections. Pharmacoeconomics 2005; 23: 945–964.
Tsiatis AC, Manes B, Calder C, Billheimer D, Wilkerson KS, Frangoul H . Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. Bone Marrow Transplant 2004; 33: 937–941.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zirakzadeh, A., Gastineau, D., Mandrekar, J. et al. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 41, 385–392 (2008). https://doi.org/10.1038/sj.bmt.1705912
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705912
Keywords
This article is cited by
-
Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantation
Bone Marrow Transplantation (2023)
-
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
Annals of Hematology (2023)
-
The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer
Infectious Diseases and Therapy (2022)
-
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
Annals of Hematology (2016)
-
Driving forces of vancomycin-resistant E. faecium and E. faecalis blood-stream infections in children
Antimicrobial Resistance and Infection Control (2014)